It is an 83-amino-acid peptide bearing an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus
For a patient starting at 230 pounds, this translates to approximately 30 pounds lost in three months, reaching results that often take other programs six months to a year to achieve
This dual-action approach not only helps regulate appetite and blood sugar levels but also sets it apart from other treatments
The single biggest lever is the price per prescription, because the long-term bill is mostly volume multiplied by a high unit price that has not come down much. Before this work, the surge in these prescriptions was easy to see in headlines but hard to size at the national level, and easy to mistake for a cost borne mainly by the people taking them
Patients have been treated for complications such as dangerously low blood sugar, intense nausea, and pancreatitis, sometimes linked to misuse of compounded or online-sourced versions
More research in this area is needed, however